Heterogeneity of treatment related myeloid neoplasms (tMN) might be partially related to inadvertent inclusion of coincidental second disease and neoplasia due to genetic predisposition. Clinical features or traditional morphology and… Click to show full abstract
Heterogeneity of treatment related myeloid neoplasms (tMN) might be partially related to inadvertent inclusion of coincidental second disease and neoplasia due to genetic predisposition. Clinical features or traditional morphology and cytogenetics are not sufficiently distinctive for possible
               
Click one of the above tabs to view related content.